相关实验视频

Updated: Jun 12, 2025

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues

Published on: July 14, 2015

通过分子动态结构建模合理化的蛋白质酶基质受体hRpn13的PROTAC链接器区域的优化

Xiuxiu Lu¹, Venkata R Sabbasani², Bakar Hassan¹

¹Protein Processing Section, Center for Structural Biology, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA.

The Journal of biological chemistry

|April 20, 2025

概括

研究人员通过优化链接器开发了一种更强大的蛋白质溶解向嵌合体 (PROTAC),从而使向hRpn13在癌症治疗中的有效性增加了两倍. 这一进步有助于制定癌症治疗策略.

科学领域:

生物化学生物化学
分子生物学分子生物学
癌症治疗方法癌症治疗方法

背景情况:

蛋白质酶基质受体hRpn13是癌症治疗的验证标.
向hRpn13蛋白解的嵌合体 (PROTACs) 通过向hRpn13蛋白解产物 (hRpn13^Pru) 来诱导亡.

研究的目的:

通过修改链接器区域来优化针对 hRpn13 的 PROTAC.
评估结构建模和分子动力学在完善 PROTAC 设计中的实用性.

主要方法:

基于HRpn13^Pru的PROTAC系列的合成 - 针对XL5与各种链接器.
评估PROTAC诱导的hRpn13^Pru降解和细胞亡.
应用分子动力学和结构建模来预测疗效.
2D核磁共振 (NMR) 光谱学用于表征PROTAC:蛋白质复合体.

主要成果:

XL5-VHL-7,具有-CH2基连接器,显示hRpn13降解和亡诱导的功效提高了2倍.
实验数据与分子动力学和结构建模的预测有很好的相关性.
核磁共振检测证实了hRpn13:PROTAC:VHL复合物的形成,支持结构模型,并表明对XL5-VHL-7有更高的亲和力.

结论:

优化hRpn13 PROTAC中的链接器显著提高功效和治疗疗效.
结构建模和分子动力学是指导PROTAC优化的宝贵工具,尽管目前的局限性.
开发的PROTAC,XL5-VHL-7,代表了针对hRpn13进行癌症治疗的有希望的进展.

关键词:

这就是NMR的NMR.这就是PROTAC.在 hRpn1313 中使用.分子动力学分子动力学分子建模分子建模蛋白质酶体蛋白质组是什么蛋白质降解蛋白质降解

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

相关概念视频

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

Directing Proteins to the Rough Endoplasmic Reticulum

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...